Patent US4594357A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4594357A Expired / Lapsed US ⏱️ 0.0 years remaining

Depot antiinflammatory agents

Assignee: Troponwerke GmbH
•
Filing: 1984-06-20
•
Granted: 1986-06-10
•
Expires: 2004-06-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to depot formulations containing, as an active antiinflammatory and/or analgesic agent a compound of Formula I, infra together with a suspension medium. Typical suspension agents are glycerides and/or esters of mono- or poly-hydric alcohols as well as selected ethers, alcohols and amides.

Inventors

  • 👤 Hans-Dieter Dell
  • 👤 Bernhard Pelster
  • 👤 Reinhold Kraus
  • 👤 Detlef Schierstedt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 07:39
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/10; A61K47/00; A61K47/44; A61K31/00; A61K31/185; A61K31/19; A61K31/195; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/455; A61K47/06; A61K47/08; A61K47/14; A61K9/0012; A61K9/0019

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 118 words
A depot agent for intramuscular use containing 3-80% by weight of a compound of the formula (I) ##STR4## in which R 1 -R 5 represents hydrogen, halogen, alkyl with 1 to 4 C atoms or trihalogenoalkyl, X represents a CH group and Y represents hydrogen, metal ions, alkyl with 1-6 C atoms, alkoxy, alkoxyalkyl, hydroxyalkyl, hydroxyalkoxyalkyl or trihalogenoalkyl, the number of C atoms in each case being between 1 and 6 and to be straight-chain or branched and a suspension medium containing one or more suspension agents selected from the group consisting of: viscoleo, isopropyl myristate, ethyl oleate, castor oil, sesame oil, arachis oil, cottonseed oil, almond oil, olive oil, neat's foot oil, neutral oil and maize oil.
Claim 2
Dependent Claim 118 words
A depot agent for intramuscular use containing 3-80% by weight of a compound of the formula (I) ##STR4## in which R 1 -R 5 represents hydrogen, halogen, alkyl with 1 to 4 C atoms or trihalogenoalkyl, X represents a CH group and Y represents hydrogen, metal ions, alkyl with 1-6 C atoms, alkoxy, alkoxyalkyl, hydroxyalkyl, hydroxyalkoxyalkyl or trihalogenoalkyl, the number of C atoms in each case being between 1 and 6 and to be straight-chain or branched and a suspension medium containing one or more suspension agents selected from the group consisting of: viscoleo, isopropyl myristate, ethyl oleate, castor oil, sesame oil, arachis oil, cottonseed oil, almond oil, olive oil, neat's foot oil, neutral oil and maize oil.
Claim 3
Dependent Claim 68 words
A depot agent for intramuscular use containing a compound of the formula (I) according to claim 1, in which R 3 and R 4 represents hydrogen, R 1 , R 2 and R 5 represents methyl, trifluoromethyl or chlorine, X represents a CH group and Y represents hydrogen, metal ions, alkyl with 1 to 4 C atoms or by trihalogeno alkyl and a suspension medium of claim 1.
Claim 4
Dependent Claim 69 words
A depot agent for intramuscular use containing a compound of the formula (I) according to claim 1, in which: R 3 and R 4 represents hydrogen, R 1 , R 2 and R 5 represents methyl, trifluoromethyl or chlorine, X represents a CH group and Y represents hydrogen, a metal ion, alkyl with 1 to 4 C atoms or by substituted alkyl, and a suspension medium of claim 1.
Claim 5
Dependent Claim 21 words
A depot agent for intramuscular use containing the compound of the formula (I) according to claim 1, which is 2-(2-hydroxyethoxy)-ethyl N-(α,α,α-trifluoro-m-toluene)-anthranilate.
Claim 6
Dependent Claim 21 words
A depot agent for intramuscular use containing the compound of the formula (I) according to claim 1, which is ethoxymethyl N-(2,6-dichloro-m-tolyl)-anthranilate.
Claim 7
Dependent Claim 20 words
A depot agent for intramuscular use containing the compound of the formula (I) according to claim 1, which is butyl-N-(α,α,α-trifluoro-m-tolyl)-anthranilate.
Claim 8
Dependent Claim 21 words
A depot agent for intramuscular use containing the compound of the formula (I) according to claim 1, which is ethyl N-(α,α,α-trifluoro-m-tolyl)-anthranilate.
Claim 9
Dependent Claim 21 words
A depot agent for intramuscular use containing the compound of the formula (I) according to claim 1, which is isopropyl N-(α,α,α-trifluoro-m-tolyl)-anthranilate.
Claim 10
Dependent Claim 62 words
A depot agent for intramuscular use containing a suspension agent and at least one compound from the groups: N-(α,α,α-trifluoro-m-tolyl)-anthranilic acid (1), N-(2,3-xylyl)-anthranilic acid (2), N-(2,6-dichloro-m-tolyl)-anthranilic acid (3), N-(3-chloro-o-tolyl)-anthranilic acid (4), N-(2,3-dichloro-phenyl)-anthranilic acid (5), N-(α,α,α-trifluoro-m-toluidine nicotinic acid (6), 2-(2,3-xylidino)-nicotinic acid (7), 2-(2-methyl-3-trifluoromethylanilino)-nicotinic acid (8), 2-(3-chloro-o-toluidine)-nicotinic acid (9), 2-(2,6-xylidino)-nicotinic acid (10), 2-(2-hydroxyethoxy)-ethyl N-(α,α,α-trifluoro-m-tolyl)-anthranilate (11), ethoxymethyl N-(2,6-dichloro-o-tolyl)-anthranilate (12), butyl(-N-α,α,α-trifluoro-m-tolyl)-anthranilate (13), ethyl-N-(α,α,α-trifluoro-m-tolyl)-anthranilate (14) and isopropyl-N-(α,α,α-trifluoro-m-tolyl)-anthranilate (15).
Claim 11
Dependent Claim 62 words
A depot agent for intramuscular use containing a suspension agent and at least one compound from the groups: N-(α,α,α-trifluoro-m-tolyl)-anthranilic acid (1), N-(2,3-xylyl)-anthranilic acid (2), N-(2,6-dichloro-m-tolyl)-anthranilic acid (3), N-(3-chloro-o-tolyl)-anthranilic acid (4), N-(2,3-dichloro-phenyl)-anthranilic acid (5), N-(α,α,α-trifluoro-m-toluidine nicotinic acid (6), 2-(2,3-xylidino)-nicotinic acid (7), 2-(2-methyl-3-trifluoromethylanilino)-nicotinic acid (8), 2-(3-chloro-o-toluidine)-nicotinic acid (9), 2-(2,6-xylidino)-nicotinic acid (10), 2-(2-hydroxyethoxy)-ethyl N-(α,α,α-trifluoro-m-tolyl)-anthranilate (11), ethoxymethyl N-(2,6-dichloro-o-tolyl)-anthranilate (12), butyl(-N-α,α,α-trifluoro-m-tolyl)-anthranilate (13), ethyl-N-(α,α,α-trifluoro-m-tolyl)-anthranilate (14) and isopropyl-N-(α,α,α-trifluoro-m-tolyl)-anthranilate (15).
Claim 12
Dependent Claim 28 words
A depot agent according to claim 1, characterised in that it contains one or more suspension agents from the group: viscoleo, isopropyl myristate, ethyl oleate and neutral oil.
Claim 13
Dependent Claim 83 words
A depot agent according to claim 1, characterised in that it contains a compound of the formula (I) according to any of claims 1, 2, 3 or 4 in an amount of 10 to 75% by weight, and a suspension agent selected from viscoleo, isopropyl myristate, ethyl oleate, castor oil, sesame oil, arachis oil, cottonseed oil, almond oil, olive oil, neat's foot oil, neutral oil and maize oil in an amount of 5 to 90% by weight, preferably 20 to 80% by weight.

References Cited (Backward Citations)

US3590039A Cited
US3673243A Cited
US3678094A Cited
US3778470A Cited
US4307113A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-06-09 1989-12-09 1990-06-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-06-09 1993-12-09 1994-06-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-06-09 1997-12-09 1998-06-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag